Effectiveness of Mobile-health Self Management on Quality of Life of Patients Undergoing Chemotherapy
MANNER
1 other identifier
interventional
50
0 countries
N/A
Brief Summary
The study will design and evaluate the use of mobile-health based self-management on self-efficacy and quality of life of patients undergoing chemotherapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable cancer
Started Jun 2023
Shorter than P25 for not_applicable cancer
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 8, 2023
CompletedFirst Posted
Study publicly available on registry
May 30, 2023
CompletedStudy Start
First participant enrolled
June 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2023
CompletedMay 30, 2023
May 1, 2023
3 months
May 8, 2023
May 27, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Patient's Quality of life
The patient's quality of life will be assessed before (T0) and after intervention (T1). The measurement will use EORTC. The score will range from 0-100, where higher score reflects a better quality of life.
Four weeks
Patient's Self-efficacy
The patients self-efficacy will be measured pre and post intervention. The measurement will use the Self-Efficacy for Managing Chronic Disease Scale. The scale has been widely used in cancer setting. Respondents will rate their confidence to perform six self-management behaviours (1 = 'not at all confident' to 10 = 'totally confident'). A mean score is calculated (range 1 to 10). A high score indicates high self-efficacy.
four weeks
Study Arms (1)
Mobile health self-management
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- adult patients diagnosed with cancer
- patients who use smart phone
You may not qualify if:
- patients with cancer with comorbidity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
May 8, 2023
First Posted
May 30, 2023
Study Start
June 15, 2023
Primary Completion
August 31, 2023
Study Completion
September 30, 2023
Last Updated
May 30, 2023
Record last verified: 2023-05